B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment

Distinct plasma immune signatures in ME/CFS are present early in the course of illness

(2015) M. Hornig et al.   Science Advances

Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients

(2014) Ana Luisa Calich et al.   JOURNAL OF AUTOIMMUNITY

Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study

(2014) P. S. Sorensen et al.   NEUROLOGY

Autoimmune Basis for Postural Tachycardia Syndrome

(2014) Hongliang Li et al.   Journal of the American Heart Association

Anti-CD20 monoclonal antibodies: Beyond B-cells

(2013) Irit Avivi et al.   BLOOD REVIEWS

The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment

(2013) G. Cambridge et al.   JOURNAL OF AUTOIMMUNITY

Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review

(2013) Tamara Castillo-Trivino et al.   PLoS One

Epitopes of Microbial and Human Heat Shock Protein 60 and Their Recognition in Myalgic Encephalomyelitis

(2013) Amal Elfaitouri et al.   PLoS One

Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type

(2013) Catherine Thieblemont et al.   SEMINARS IN CANCER BIOLOGY

Rituximab for the treatment of rheumatoid arthritis: an update

(2013) Chi Chiu Mok   Drug Design Development and Therapy

Complex regional pain syndrome, prototype of a novel kind of autoimmune disease

(2012) Andreas Goebel et al.   AUTOIMMUNITY REVIEWS

Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults

(2012) Cindy M. Chang et al.   CANCER

Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls

(2012) A. S. Bradley et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity

(2012) YK Onno Teng et al.   ARTHRITIS RESEARCH & THERAPY

Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis

(2011) David B. Clifford   ARCHIVES OF NEUROLOGY

Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis

(2011) Jérémie Sellam et al.   ARTHRITIS AND RHEUMATISM

Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care

(2011) Luis C Nacul et al.   BMC Medicine

Evidence for a heritable predisposition to Chronic Fatigue Syndrome

(2011) Frederick Albright et al.   BMC Neurology

The functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carers

(2011) Luis C Nacul et al.   BMC PUBLIC HEALTH

Neutropenia after rituximab treatment

(2011) Ofir Wolach et al.   CURRENT OPINION IN HEMATOLOGY

Outcome measurement in functional somatic syndromes: SF-36 summary scores and some scales were not valid

(2011) Andreas Schröder et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome

(2011) Danielle Kohr et al.   PAIN

Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study

(2011) Øystein Fluge et al.   PLoS One

Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial

(2010) J. M. Meijer et al.   ARTHRITIS AND RHEUMATISM

Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: Results of a randomized, double-blind, placebo-controlled, phase I/II study

(2010) Mikkel Østergaard et al.   ARTHRITIS AND RHEUMATISM

Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis

(2010) H. Huang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series

(2009) Øystein Fluge et al.   BMC Neurology

The late adverse events of rituximab therapy – rare but there!

(2009) Ron Ram et al.   LEUKEMIA & LYMPHOMA